174 related articles for article (PubMed ID: 21611920)
1. [New therapeutic options for advanced thyroid cancer].
Willhauck MJ; Schott M; Kreissl MC; Fassnacht M; Spitzweg C
Dtsch Med Wochenschr; 2011 Jun; 136(22):1165-8. PubMed ID: 21611920
[No Abstract] [Full Text] [Related]
2. Harvesting the low-hanging fruit: kinase inhibitors for therapy of advanced medullary and nonmedullary thyroid cancer.
Fagin JA; Tuttle RM; Pfister DG
J Clin Endocrinol Metab; 2010 Jun; 95(6):2621-4. PubMed ID: 20525911
[No Abstract] [Full Text] [Related]
3. Sorafenib and sunitinib.
Kim A; Balis FM; Widemann BC
Oncologist; 2009 Aug; 14(8):800-5. PubMed ID: 19648603
[No Abstract] [Full Text] [Related]
4. Targeted molecular therapies in thyroid carcinoma.
Romagnoli S; Moretti S; Voce P; Puxeddu E
Arq Bras Endocrinol Metabol; 2009 Dec; 53(9):1061-73. PubMed ID: 20126863
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network.
Massicotte MH; Brassard M; Claude-Desroches M; Borget I; Bonichon F; Giraudet AL; Do Cao C; Chougnet CN; Leboulleux S; Baudin E; Schlumberger M; de la Fouchardière C
Eur J Endocrinol; 2014 Apr; 170(4):575-82. PubMed ID: 24424318
[TBL] [Abstract][Full Text] [Related]
6. [New therapeutic regimes in metastasic renal-cell carcinoma].
Bierer S; Hertle L; Nitschmann S
Internist (Berl); 2008 Jan; 49(1):114-7. PubMed ID: 18704353
[No Abstract] [Full Text] [Related]
7. Therapy for metastatic RCC--questions remain.
Breau RH; Leibovich BC
Nat Rev Urol; 2009 Nov; 6(11):580-1. PubMed ID: 19890336
[No Abstract] [Full Text] [Related]
8. Novel molecular targeted therapies for refractory thyroid cancer.
Perez CA; Santos ES; Arango BA; Raez LE; Cohen EE
Head Neck; 2012 May; 34(5):736-45. PubMed ID: 21544895
[TBL] [Abstract][Full Text] [Related]
9. Health policy: The UK 'postcode lottery' in renal cell carcinoma.
Larkin J; Gore M
Nat Rev Urol; 2009 Dec; 6(12):636-8. PubMed ID: 19956190
[No Abstract] [Full Text] [Related]
10. CCR drug updates: sorafenib and sunitinib in renal cell carcinoma.
Stein MN; Flaherty KT
Clin Cancer Res; 2007 Jul; 13(13):3765-70. PubMed ID: 17606705
[No Abstract] [Full Text] [Related]
11. [New drugs; sunitinib and sorafenib].
Bellersen L
Ned Tijdschr Geneeskd; 2008 Feb; 152(8):469-70; author reply 470. PubMed ID: 18363211
[No Abstract] [Full Text] [Related]
12. Kidney cancer: Does hypothyroidism predict clinical outcome?
Rini B
Nat Rev Urol; 2011 Jan; 8(1):10-1. PubMed ID: 21116300
[No Abstract] [Full Text] [Related]
13. Tyrosine kinase inhibitors and the thyroid.
Sherman SI
Best Pract Res Clin Endocrinol Metab; 2009 Dec; 23(6):713-22. PubMed ID: 19942148
[TBL] [Abstract][Full Text] [Related]
14. Autophagic activation potentiates the antiproliferative effects of tyrosine kinase inhibitors in medullary thyroid cancer.
Lin CI; Whang EE; Lorch JH; Ruan DT
Surgery; 2012 Dec; 152(6):1142-9. PubMed ID: 23158184
[TBL] [Abstract][Full Text] [Related]
15. Second-line sunitinib as a feasible approach for iodine-refractory differentiated thyroid cancer after the failure of first-line sorafenib.
Marotta V; Di Somma C; Rubino M; Sciammarella C; Modica R; Camera L; Del Prete M; Marciello F; Ramundo V; Circelli L; Buonomano P; Colao A; Faggiano A
Endocrine; 2015 Aug; 49(3):854-8. PubMed ID: 25305056
[No Abstract] [Full Text] [Related]
16. Targeted therapies in the treatment of advanced/metastatic NSCLC.
Pallis AG; Serfass L; Dziadziusko R; van Meerbeeck JP; Fennell D; Lacombe D; Welch J; Gridelli C
Eur J Cancer; 2009 Sep; 45(14):2473-87. PubMed ID: 19596191
[TBL] [Abstract][Full Text] [Related]
17. Current status of molecularly targeted drugs for the treatment of advanced thyroid cancer.
Takami HE
Endocr J; 2011; 58(3):151-3. PubMed ID: 21383525
[TBL] [Abstract][Full Text] [Related]
18. New weapons to snuff out kidney cancer.
Wetherbee SL
Nursing; 2006 Dec; 36(12 Pt.1):58-63; quiz 64. PubMed ID: 17135925
[TBL] [Abstract][Full Text] [Related]
19. About tyrosine kinase inhibitors (TKIs) in prostate cancer: where do we go from here?
Aragon-Ching JB; Dahut WL
Ann Oncol; 2010 Jan; 21(1):183-4. PubMed ID: 19903718
[No Abstract] [Full Text] [Related]
20. Targeted therapy in advanced non-small-cell lung cancer.
Gettinger S
Semin Respir Crit Care Med; 2008 Jun; 29(3):291-301. PubMed ID: 18506667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]